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Crystals of Escherichia coli ribonucleotide reductase protein Rl have been grown in complex with a synthetic peptide corresponding to the carboxyl 
end of protein R2. Good quality crystals could only be obtained after improvement of the purification protocol and are of the space group R32 
with hexagonal cell axes a = b = 226 8, and c = 341 A. They contain 3 subunits per asymmetric unit and diffract to 2.5 8, resolution in synchrotron 
radiation. A multiple isomorphous replacement map at 5.5 A, improved by solvent flattening, shows that the dimeric molecules are elongated, about 
110 A long. The dimer is thin in the middle around the molecular two-fold axis. The subunit is shaped like a bowl, probably with the active site 
in its center. 
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1. I~RDDUCTION 
Ribonucleotide reductase (RNR) is an essential en- 
zyme for DNA synthesis. It catalyses the reduction of 
all four ribonucleotides to their corresponding deoxyri- 
bonucleotides [l]. In Escherichiu coli and higher organ- 
isms RNR consists of two homodimeric unequal pro- 
teins Rl and R2 (for reviews see [24]). A catalytically 
active enzyme is formed by a one to one complex of the 
two proteins in the presence of Mg” and ATP. The 
carboxyl end of R2 contributes to a large extent to the 
binding between the two proteins, and peptides of the 
carboxyl end of R2 have been shown to inhibit forma- 
tion of the active holoenzyme [5-8]. 
Each subunit of the protein Rl has two different 
effector binding sites for allosteric regulation. One site 
regulates the overall activity with ATP and dATP as 
effecters while the other site regulates ubstrate specific- 
ity with deoxyribonucleoside triphosphates as effecters. 
Rl also contains redox active cysteines which become 
oxidized during catalytis. To regenerate active enzyme, 
this disulfide bridge has to be reduced. This can be done 
by at least two different systems, the glutaredoxin and 
thioredoxin systems 19). 
The Rl protein is about twice as large as the R2 
protein in most species. In E. co/i, Rl has a molecular 
weight of 2 x 83 kDa where each peptide consists of 761 
amino acid residues [lo]. The smaller R2 protein 
(2 x 43.4 kDa) contains a tyrosyl free radical close to a 
binuclear iron center [I 11. 
*Corresponding author. 
For several years we have worked on the structure 
dete~ination of ribonucleotide reductase from E. co&. 
The main difficulty of this work has been to obtain 
useful crystals for crystallographic studies. The R 1 pro- 
tein has been crystallized in at least ten different crystal 
forms, and R2 in three orthorhombic crystal forms [12]. 
Most of the crystal forms were not suitable for high- 
resolution crystallography. Crystals of the holoenzyme 
have been obtained, but they have large cell dimensions 
and are X-ray sensitive and thus not useful for structure 
determination. By extensive exploration of different 
crystallization conditions in combination with im- 
proved enzyme preparation we were able to obtain crys- 
tals of good quality of the R2 protein [12]. With this 
crystal form the three-dimensional structure of R2 
could be solved at 2.2 A resolution [13]. 
Most of the different crystal forms of Rl contain a 
large number of subunits per asymmetric unit, and are 
generally sensitive to X-ray radiation. Some of the crys- 
tal forms could only be obtained from one single en- 
zyme preparation. This paper will describe a new, im- 
proved purification method for Rl, crystallization of a 
complex of Rl and a 20-residues-long peptide corre- 
sponding to the carboxyl end of R2, and crystallogra- 
phic investigations of the resulting rhombohe~ai crys- 
tal form. 
2. MATERIALS AND METHODS 
Protein Rl was purified from the overproducing strain C600/ 
pLHS1 [14]. In the new enzyme purification procedure, the protocol 
was followed as described in [l&16] to the step after the ammonium 
sulphate precipitation. The crude precipitate was dissolved in 50 mM 
Tris buffer pH 7.6 and frozen with 10% glycerol in 1 ml portions. A 
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column was packed with Phenyl-Sepharose CL4B (Pharmacia) 
(1.6 x 11 cm), and connected to an FPLC-system. After equilibration 
with 0.75 M ammonium sulphate, 1 ml of the sample was thawed and 
mixed with 1 ml 1.5 M ammonium sulphate before injection. The 
separation protocol involved two consecutive 120-min linear gradi- 
ents. The first gradient was run from 0.75 M ammonium-sulphate o
50 mM Tris pH 7.6 and 5 mM DTT, and the other from 50 mM 
T&buffer pH 7.6 with 5 mM DTT to distilled water containing 3 mM 
DTT. The flow rate was set to 1 mUmin and l-ml fractions were 
collected. Tris buffer pH 7.6 (15 ,~l of 1 M) was immediately added 
to each 1 ml fraction (Fig. 1). Centricon (Amicon) was used to concen- 
trate and change buffer on the purified protein, before addition of the 
peptide for crystallization. 
The 20-residue peptide (Y L V G Q I D S E V D T D D L S N F 
Q L) corresponding to the carboxyl end of R2 was synthesized by the 
solid-phase peptide synthesis procedure using an applied Biosystems 
430A Synthesizer. Freeze-dried peptide (20 mg) was dissolved in 200 
~1 10 mM Tris solution with pH approximately 10. The pH was 
lowered to 6.5 with 100~125 mM sodium citrate pH 6.0. For desalting 
a 2 ml G25 column equilibrated with 25 mM sodium citrate buffer pH 
6.0 was used. 
The best crystals are obtained using the hanging drop method with 
droplets of 10 ,~1(5 ~1 protein mixture and 5 ,~l well solution). Culture 
cells (Costar) are used with a one ml well solution of 17% lithium 
sulphate and 10 mM magnesium sulphate in buffer (25 mM sodium 
citrate pH 6.0). (All chemicals were from Merck). A concentrated 
protein solution is adjusted to a concentration of 30 mg/ml in buffer 
and diluted to 15 mg/ml with the peptide solution. For good crystal 
growth, a 20-fold molar excess of the peptide is needed. The protein 
mixture is incubated at +5”C for half an hour before crystallization, 
and crystals grow at the same temperature within one week (Fig. 2). 
Space group determination was performed using precession and 
oscillation films and the Buddha auto-indexing program written by M. 
Blum [17]. Data have been processed in space group R32 with hexag- 
onal cell axes a = b = 226 A and c = 341 A. The corresponding rhom- 
bohedral cell has the cell dimensions a = b = c = 173 A and 
a = B = y = 82”. The crystals diffract to about 2.5 A in synchrotron 
radiation. 
Native and heavy atom derivative data were collected on a Xentron- 
its multiwire area detector (Nicolet) on a Rigaku rotating anode 
source. Native data at higher resolution have also been collected at the 
synchrotron (station X31, EMBL) in Hamburg (Table I). Data reduc- 
tion and scaling were performed with the CCP4 program suite (Da- 
resbury, England). 
Patterson maps were investigated using a real space Patterson 
search program (RSPS) written by S. Knight [18]. The derivative with 
the metal cluster Ta,Br,, gave a difference Patterson map that was 
possible to solve with three sites per asymmetric unit. Phases from this 
derivative were good enough to allow us to lind heavy atom positions 
in other derivatives that were consistent with their difference Patterson 
maps. 
Heavy atom parameters, from four derivatives, were further refined 
in Heavy [19], first against the origin removed Patterson maps and 
then using lack of closure refinement. Some statistics from the refine- 
ment to 5.5 A are shown in Table I. 
To test binding of heavy atom labeled peptide, the tyrosine was 
iodinated and the iodinated peptide was purified on a prepacked 
FPLC column, Pep-RPC, from Pharmacia. No crystals were obtained 
from crystallizations using mono- and diiodinated peptides. A longer 
peptide (22 residues) with a Cys and Ser added at the N-terminus was 
labeled with mercury and used in the same crystallization procedure 
but no crystals were obtained. 
Calculation of the solvent content [20] indicated three or four mon- 
omers in one asymmetric unit. Three subunits would give a V,,, of 3.4, 
while four subunits would give a V,,, of 2.4. From the MIR map at 5.5 
A resolution it was clear that the asymmetric unit contained three 
subunits; the protein and solvent regions were obvious (Fig. 3a). The 
V, for three subunits per asymmetric unit corresponds to a relatively 
high solvent content of 63%. The phases were further improved by 
_ 
, \ 
Fig. 1. Elution profile from the phenyl-sepharose column. In the first 
elution gradient ammonium sulphate is substituted by T&buffer, in 
the second gradient the Tris-buffer is substituted by distilled water. 
solvent flattening [21] (Fig. 3b). From this map a skeletonized repre- 
sentation of the molecule was calculated using the bones option in 0 
[22,23]. The bone atoms were assigned to different subunits and 
coloured. A bones representation of one Rl dinner is shown in Fig. 4. 
The crystal packing of the Rl-dimers, and the choice of the three 
subunits in the asymmetric unit is shown in Fig. 5a,b. From the 
relations between the three subunits in the asymmetric unit, phases can 
be further improved by three-fold averaging [24]. 
3. RESULTS AND DISCUSSION 
Two of the earlier obtained crystal forms of the Rl 
protein have been suitable for further crystallographic 
studies: one hexagonal form (P622) with cell dimensions 
a = b = 96 A and c = 220 A, and a monoclinic form 
(C2) with cell parameters a = 211.5 A, b = 119.6 A, 
c = 129.5 A and /3 = 123.9”. Both crystal forms were 
grown with lithium sulphate as precipitant and contain 
one and two subunits per asymmetric unit, respectively. 
Unfortunately, these crystals could only be obtained 
from single R 1 preparations and we have only managed 
to collect native data to 3.0 A for these crystal forms so 
far. 
Our R32 crystal form was obtained by using an im- 
proved fast enzyme preparation and by adding a syn- 
thetic polypeptide to the protein solution. The peptide 
Fig. 2. Crystals of the ribonucleotide reductase Rl protein complex 
with a 20-residue-long peptide from the carboxyl end of R2. The 
largest crystal has a size of 0.7 x 0.6 x 0.4 mm. 
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Fig. 3. Comparison of an 8 A layer in the c-direction at 5.5 A resolution (1 o cut) of (a) the MIR map and (b) the solvent flattened map. 
added has a length of 20 residues and the same sequence 
as the C-terminal residues of the R2 protein. The re- 
maining crystallization conditions are similar to those 
used for growing the hexagonal (P622) and monoclinic 
(C2) crystals mentioned above. 
The main difference between the new and the old 
enzyme preparation protocol is that one desalting and 
two ion-exchange separation steps are replaced by a 
purification step on a Phenyl-Sepharose column. In the 
final protocol the purification time is reduced to l/4 
compared to the original protocol [15,16]. The new pu- 
rification method gives active protein as pure as with the 
old method. 
Crystals are only obtained from a narrow range of the 
purification: only the top fraction gives useful crystals. 
We also found that the age of the protein was an impor- 
tant parameter for crystallization and the use of fresh 
sample was necessary for obtaining crystals of good 
quality. If the purified protein has been stored in the 
freezer (-70°C) for more than three months no crystals 
can be obtained. 
The many difficulties in the crystallization of the Rl 
protein may be related to the cysteines involved in the 
activity of the protein, to flexible parts in the protein, 
and to conformational changes. The Rl protein con- 
tains 11 cysteines per subunit that have to be kept re- 
duced during purification. Mutation studies show that 
five of the cysteines are important for the activity of the 
enzyme [25-301. Two of these are located close to the 
C-terminus of the protein and interact with thioredoxin 
or glutaredoxin. They have been suggested to be in- 
volved in transfer of reducing power from the surface 
to the active site. 
We have tried to stabilize the protein by adding effec- 
Table I 
Datacollection and heavy atom refinement’ 
Data-set’ Resol 
(A) 
Reflections 
(no.) 
Compl. R-sym A-iso Soak4 Sites Phasing’ Centric6 
(8) (%) (%) (mMW (no.) power R-factor 
F& R- 
Native 
Nat1 
Nat2 
Nat3 
Merged Natl-3 
Derivatives 
RAu(W, 
W’t(CN)., 
Ta,Rr,, 
Ta,Br,, 
UO,Ac, 
UO,Ac, 
3.0 46,000 70 4 _ _ _ _ _ 
3.0 42,000 62 5 _ _ _ 
2.7 82,000 90 9 _ _ _ _ _ 
2.7 84,000 92 1 0 _ _ _ _ 
5.5 9,600 82 7 11 0.1/24 3 1.2 0.7 
5.5 9,200 78 3 17 1 O/26 3 1.7 0.8 
5.5 6,600 56 7 21 0.5120 3 2.3 0.9 
5.5 5,500 47 5 20 0.5120 3 2.0 0.7 
5.5 6,800 58 5 19 5195 8 1.8 0.9 
5.5 7,100 61 4 13 5144 8 1.6 0.8 
’ Statistics from Heavy. Total figure of merit; 0.78 (10,646 reflections). 
‘Data-sets Natl, Nat2 and derivatives were collected on a Xentronics (Nicolet) area detector. Data Nat3 was collected on the image plate at the 
synchrotron station X31 in Hamburg. 
‘The derivatives were scaled against Nat1 using RSTATS. 
4The crystals were soaked in the mother liquor, where the desired heavy metal solution was added to the appropriate concentration. 
5 F& (phasing power) = r.m.s.(F,lr.m.s. (lack of closure, where Fu is the calculated heavy atom structure factor. 
6& = 1 C II%obs~l - I&cca,c>ll E I%,& 
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Fig. 4. Skeletonized representation of the Rl dimer viewed along the molecular two-fold axis. The closest hree-fold axis is in the vertical direction 
in front of the dimer. 
tors and inhibitors, but for various reasons most of the 
crystals obtained have not been suitable for crystallo- 
graphic investigations. Most of the crystal forms have 
a large number of molecules in the asymmetric unit 
and/or are X-ray sensitive. Crystals of the Rl protein 
with the R2 20-mer are considerably more stable than 
any of the earlier obtained crystal forms. One crystal 
usually lasts for three days in the rotating anode beam 
and properly aligned it gives one full data-set o 3 A. 
Inhibition of activity with C-terminal peptides from 
R2 has been investigated, and the 20-residues-long pep- 
tide used in our investigation is known to strongly in- 
hibit the specific activity of E. coli RNR [8]. The disso- 
ciation constant is 0.09 mM. The amount of peptide in 
our crystallizations is thus sufficient for formation of a 
complex of Rl and the added 20-residue peptide. 
Seven different peptides, with lengths varying from 9 
to 30 amino acids, were prepared and used under the 
same crystallization conditions as the 20-mer, but did 
not give any crystals. Our conclusion is, that the peptide 
in some way makes interactions important for the crys- 
tal packing and any shorter or longer peptides will cause 
unfavorable packing contacts. 
The skeletonized representation of the Rl subunit has 
Fig. 5. Three Rl dimers cluster around the three-fold axes forming hexamers which stack on top of each other in three layers along the c-axis of 
the cell. The two unique hexamers are related by an approximate 3A translation and 20” rotation. For computational reasons, the three Rl subunits 
in the asymmetric unit are chosen close in space. One subunit is selected from one hexamer and one dimer from a nearby hexamer. Each hexamer 
has crystallographic three-fold symmetry, but the molecular dimer is related by a crystallographic two-fold axis in only one of the two hexamers. 
(a) Two hexamers are shown positioned around two threefold axes (a = 2/3, b = 113 and a = 113, b = 2/3) 116 to l/2 along the c-axis. The 
non-crystallographically related subunits are marked A, B and C. Subunits chosen as the asymmetric unit are shaded. The top of the A subunits 
always pack against the bottom of the B subunits or vice versa, and subunit C against C. Subunits B-A have closer contact than C-C subunits. 
(b) The packing in the hexagonal plane. The two-fold axes shown are positioned in a plane on 113 of the c-axis, and the subunits illustrated here 
are located under this plane on l/61/3 of the c-axis. 
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the shape of a large bowl and the two bowls that form 
the dimer are roughly perpendicular to each other. We 
suggest hat the active site is located in the center of 
these bowls, where the main mercury and Au(CN); sites 
are located since the active site is known to contain 
cysteine residues. The distance between the gold sites of 
the presumed active sites of the dimer is 43 A. 
The length of the dimeric molecule is about 110 A and 
with a largest diameter of 75 A. We have compared our 
Rl structure with the object observed by image analysis 
of two-dimensional RI crystals [31]. Our suggestion is 
that the 110 A object they interpreted as an RI subunit 
more likely corresponds to one RI dimer. 
The dimer interaction is rather restricted. There seem 
to be more interactions within the crystallographic 
trimers than within the molecular dimers. We believe 
that the R2 dimer will fit in the cavities of the bowls and 
stabilize the RI dimer while forming the holo-complex. 
A three-dimensional structure of the large subunit with 
a R2 peptide will be of help in understanding the forma- 
tion of the RNR holo-complex. This is particularly in- 
teresting in view of the reports that the C-terminus of 
the RNR small protein from some viruses inhibits the 
formation of the RNR holoenzyme complex [6,7]. These 
virus encoded ribonucleotide reductases may serve as 
targets for anti-viral therapy [32]. 
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